University of Pennsylvania

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1740-11-14

Employees: 5K

Market Cap: -

Website: http://www.upenn.edu

Clinical Trials

The Digital Wellbeing Project

Not Applicable

Completed

Conditions: Mental Health

Interventions: Behavioral: immi
Behavioral: Control

First Posted Date: 2021-09-30

Last Posted Date: 2023-06-05

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 270

Registration Number: NCT05061966

Locations: 🇺🇸
University of Pennsylvania, Philadelphia, Pennsylvania, United States

Heart Smart: A Virtual Self-Management Program for Homebound People With Heart Failure

Not Applicable

Completed

Conditions: Heart Failure

Interventions: Other: Heart Smart Virtual Self-Management Group

First Posted Date: 2021-09-27

Last Posted Date: 2022-03-09

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 5

Registration Number: NCT05057364

Locations: 🇺🇸
Penn Medicine at Home, Bala-Cynwyd, Pennsylvania, United States

huCART-meso + VCN-01 in Pancreatic and Ovarian Cancer

Phase 1

Active, not recruiting

Conditions: Pancreatic Cancer
Serous Ovarian Cancer

Interventions: Biological: VCN-01
Biological: huCART-meso Cells

First Posted Date: 2021-09-27

Last Posted Date: 2024-11-27

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 13

Registration Number: NCT05057715

Locations: 🇺🇸
University of Pennsylvania, Philadelphia, Pennsylvania, United States

Penn SICCA Follow-up Study

Not yet recruiting

Conditions: Sjogren's Syndrome
Dry Eye

First Posted Date: 2021-09-24

Last Posted Date: 2025-02-14

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 220

Registration Number: NCT05056012

Locations: 🇺🇸
Scheie Eye Institute, Philadelphia, Pennsylvania, United States

DISE: Phenotyping Obstruction Patterns

Not Applicable

Recruiting

Conditions: Obstructive Sleep Apnea

Interventions: Other: Pharyngeal Manometry
Other: Submental Ultrasound

First Posted Date: 2021-09-20

Last Posted Date: 2024-05-31

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 241

Registration Number: NCT05050383

Locations: 🇺🇸
University of Pennsylvania, Philadelphia, Pennsylvania, United States

Programmed Allogeneic CRISPR-edited T Cells Engineered to Express Anti-CD19 Chimeric Antigen Receptor (PACE CART19) in Patients With Relapsed Or Refractory CD19+ Leukemia and Lymphoma

Phase 1

Withdrawn

Conditions: Non Hodgkin Lymphoma
Acute Lymphoblastic Leukemia
Chronic Lymphocytic Leukemia

Interventions: Biological: PACE CART19

First Posted Date: 2021-09-08

Last Posted Date: 2023-06-22

Lead Sponsor: University of Pennsylvania

Registration Number: NCT05037669

Federal Aviation Administration (FAA) National Sleep Study

Active, not recruiting

Conditions: Noise Exposure

First Posted Date: 2021-09-05

Last Posted Date: 2025-04-08

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 401

Registration Number: NCT05035940

Locations: 🇺🇸
University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, United States

Our Care Wishes - Dementia

Not Applicable

Completed

Conditions: Alzheimer Disease
Dementia
Memory Impairment

Interventions: Other: Our Memory Care Wishes

First Posted Date: 2021-09-02

Last Posted Date: 2023-06-22

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 14

Registration Number: NCT05033262

Locations: 🇺🇸
University of Pennsylvania, Philadelphia, Pennsylvania, United States

A Physical Activity Intervention to Promote Cognitive Health, Cardiovascular Health and Sleep in Older Latinos

Not Applicable

Active, not recruiting

Conditions: Mild Cognitive Impairment

Interventions: Behavioral: Tiempo Juntos Intervention

First Posted Date: 2021-09-01

Last Posted Date: 2025-05-29

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 236

Registration Number: NCT05030948

Locations: 🇺🇸
University of Pennsylvania School of Nursing, Philadelphia, Pennsylvania, United States

Naltrexone in AUD Reward Drinkers

Phase 4

Recruiting

Conditions: Alcohol Use Disorder
Alcoholism

Interventions: Drug: XR-NTX 380 mg, intramuscular injection
Behavioral: Medical Management
Drug: Placebo intramuscular injection

First Posted Date: 2021-08-31

Last Posted Date: 2025-04-15

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 60

Registration Number: NCT05028062

Locations: 🇺🇸
University of Pennsylvania Center for Studies of Addiction, Philadelphia, Pennsylvania, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy